Poland - Nowy Sącz: Antineoplastic and immunomodulating agents

Release

ID
ocds-pyfy63:2020-543335:2021-068830
Date
2021-02-10
Language
PL
Tags
award

Release in JSON

Process

ID (OCID)
ocds-pyfy63:2020-543335

Releases in JSON

Tender

Title
Poland - Nowy Sącz: Antineoplastic and immunomodulating agents
Award criteria
ratedCriteria
Award criteria details
The most economic tender

Award criteria for item 1:
- Cost: Cena (60)
- Cost: Warunki dostawy (40)

Award criteria for item 2:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 3:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 4:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 5:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 6:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 7:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 8:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 9:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 10:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 11:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 12:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 13:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 14:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 15:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 16:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 17:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 18:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 19:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 20:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 21:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 22:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 23:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 24:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 25:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 26:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 27:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 28:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 29:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 30:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 31:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 32:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 33:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 34:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 35:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 36:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 37:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 38:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 39:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 40:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 41:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 42:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 43:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 44:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 45:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 46:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 47:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 48:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 49:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 50:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 51:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 52:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 53:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 54:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 55:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 56:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 57:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 58:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 59:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 60:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 61:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 62:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 63:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 64:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 65:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 66:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 67:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 68:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 69:
- Cost: cena (60)
- Cost: termin realizacji zamówienia (40)

Award criteria for item 70:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 71:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 72:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 73:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 74:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 75:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 76:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 77:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 78:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 79:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 80:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 81:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 82:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 83:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 84:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 85:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 86:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 87:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 88:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 89:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 90:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 91:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 92:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 93:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 94:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 95:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 96:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 97:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 98:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 99:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 100:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 101:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 102:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 103:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 104:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 105:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 106:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 107:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 108:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 109:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 110:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 111:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 112:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 113:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 114:
- Cost: cena (60)
- Cost: warunki dostawy (40)

Award criteria for item 115:
- Cost: cena (60)
- Cost: warunki dostawy (40)
Main procurement category
goods
Procurement method
open
Procurement method details
Open procedure
Tender period
2021-02-10 - ?
Tenderers
Asclepios SA. ul. Hubska 44 50-502
Lek S.A. ul. Podlipie 16, 95-010
Neuca SA., ul. Forteczna 35-37, 87-100
Amgen Sp. z o.o. ul. Puławska 145 02-715
Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Salus International Sp. z o. o. ul. Pułaskiego 9, 40-273
6/Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
6/ Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
PGF SA. ul. Zbąszyńska 3, 91-342
Astra Zeneca AB 151 85 SŐDERTӒLIE SWEDEN
Janssen-Cilag Polska Sp. z o.o ul. Iłżecka 24, 02-135
/Bialmed Sp. z o.o. ul. Kazimierzowska 46/48/35, 02-546
Farmacol Logistyka Sp. z o.o. ul. Szopienicka 77, 40-431
Astellas Pharma Sp. z o.o. ul. Osmańska 14 02-823
Astra Zeneca AB 151 85 SWEDEN
Servier Polska Services Sp. z o.o. ul. Jana Kazimierza 10, 01-248
Takeda Pharma Sp. z o.o. ul. Prosta 68, 00-838
Sanofi-Aventis Sp. z o.o., 00-203 ul. Bonifraterska 17
Komtur Polska Sp. z o.o. ul. Plac Farmacji 1, 02-699
Pfizer Trading Polska Sp. z o.o. ul. Żwirki i Wigury 16B 02-092
Abbvie Sp. z o.o. ul. Postępu 21B, 02-676
Centrala Farmaceutyczna CEFARM SA 01-494 ul. Jana Kazimierza 16
9/Servier Polska Services Sp. z o.o. ul. Jana Kazimierza 10, 01-248
Konsorcjum: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
11/Farmacol Logistyka Sp. z o.o. ul. Szopienicka 77, 40-431
Urtica Sp. z o.o. ul Krzemieniecka 12054-613
Asclepios SA. ul. Hubska 44 50-502 Wrocław
Genesis Pharm Sp. z o.o. Sp. k. ul. Obywatelska 128, 94-104
Fresenius Kabi Polska Sp. z o.o. Al. Jerozolimskie 114 02-305

Tender item

ID
ocds-pyfy63:2020-543335:obj:1
Classification
CPV / 33652000
Description
Leki przeciwnowotworowe

Tender item

ID
ocds-pyfy63:2020-543335:obj:2
Classification
CPV / 33652000
Description
Calcii folinas

Tender item

ID
ocds-pyfy63:2020-543335:obj:3
Classification
CPV / 33652000
Description
Filgasterim

Tender item

ID
ocds-pyfy63:2020-543335:obj:4
Classification
CPV / 33652000
Description
Irinotecan

Tender item

ID
ocds-pyfy63:2020-543335:obj:5
Classification
CPV / 33652000
Description
Bendamustine

Tender item

ID
ocds-pyfy63:2020-543335:obj:6
Classification
CPV / 33652000
Description
Capecytabina

Tender item

ID
ocds-pyfy63:2020-543335:obj:7
Classification
CPV / 33652000
Description
Gefitinibum

Tender item

ID
ocds-pyfy63:2020-543335:obj:8
Classification
CPV / 33652000
Description
Oxaliplatin

Tender item

ID
ocds-pyfy63:2020-543335:obj:9
Classification
CPV / 33652000
Description
BCG Vaccinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:10
Classification
CPV / 33652000
Description
Ac. levofolicum

Tender item

ID
ocds-pyfy63:2020-543335:obj:11
Classification
CPV / 33652000
Description
Darbopoetyna alfa

Tender item

ID
ocds-pyfy63:2020-543335:obj:12
Classification
CPV / 33652000
Description
Bevacizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:13
Classification
CPV / 33652000
Description
Erlotinib

Tender item

ID
ocds-pyfy63:2020-543335:obj:14
Classification
CPV / 33652000
Description
Rituximab

Tender item

ID
ocds-pyfy63:2020-543335:obj:15
Classification
CPV / 33652000
Description
Obinutuzumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:16
Classification
CPV / 33652000
Description
Peruzumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:17
Classification
CPV / 33652000
Description
Trastuzumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:18
Classification
CPV / 33652000
Description
Olaparyb

Tender item

ID
ocds-pyfy63:2020-543335:obj:19
Classification
CPV / 33652000
Description
Doxorubicinum lizosomalna pegylatum

Tender item

ID
ocds-pyfy63:2020-543335:obj:20
Classification
CPV / 33652000
Description
Vinorelbinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:21
Classification
CPV / 33652000
Description
Bortezomib

Tender item

ID
ocds-pyfy63:2020-543335:obj:22
Classification
CPV / 33652000
Description
Anagrelid

Tender item

ID
ocds-pyfy63:2020-543335:obj:23
Classification
CPV / 33652000
Description
Lapatinib

Tender item

ID
ocds-pyfy63:2020-543335:obj:24
Classification
CPV / 33652000
Description
Cytarabina liposomalna

Tender item

ID
ocds-pyfy63:2020-543335:obj:25
Classification
CPV / 33652000
Description
Azacytydyna

Tender item

ID
ocds-pyfy63:2020-543335:obj:26
Classification
CPV / 33652000
Description
Octan abirateronu

Tender item

ID
ocds-pyfy63:2020-543335:obj:27
Classification
CPV / 33652000
Description
Certyzynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:28
Classification
CPV / 33652000
Description
Imatinib

Tender item

ID
ocds-pyfy63:2020-543335:obj:29
Classification
CPV / 33652000
Description
Afatynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:30
Classification
CPV / 33652000
Description
Enzalutamid

Tender item

ID
ocds-pyfy63:2020-543335:obj:31
Classification
CPV / 33652000
Description
Ozymertynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:32
Classification
CPV / 33652000
Description
Ruksolitynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:33
Classification
CPV / 33652000
Description
Ibrutynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:34
Classification
CPV / 33652000
Description
Eltrombopag

Tender item

ID
ocds-pyfy63:2020-543335:obj:35
Classification
CPV / 33652000
Description
Piksantron dimaleas

Tender item

ID
ocds-pyfy63:2020-543335:obj:36
Classification
CPV / 33652000
Description
Dasatynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:37
Classification
CPV / 33652000
Description
Brentuksymab

Tender item

ID
ocds-pyfy63:2020-543335:obj:38
Classification
CPV / 33652000
Description
Aflibercept

Tender item

ID
ocds-pyfy63:2020-543335:obj:39
Classification
CPV / 33652000
Description
Pomalidomid

Tender item

ID
ocds-pyfy63:2020-543335:obj:40
Classification
CPV / 33652000
Description
Nintedanib

Tender item

ID
ocds-pyfy63:2020-543335:obj:41
Classification
CPV / 33652000
Description
Fluvestrant

Tender item

ID
ocds-pyfy63:2020-543335:obj:42
Classification
CPV / 33652000
Description
Atezolizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:43
Classification
CPV / 33652000
Description
Niwolumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:44
Classification
CPV / 33652000
Description
Kryzotynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:45
Classification
CPV / 33652000
Description
Pembrolizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:46
Classification
CPV / 33652000
Description
Wenetoklaks

Tender item

ID
ocds-pyfy63:2020-543335:obj:47
Classification
CPV / 33652000
Description
Alektynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:48
Classification
CPV / 33652000
Description
Transtuzumab ematyzyna

Tender item

ID
ocds-pyfy63:2020-543335:obj:49
Classification
CPV / 33652000
Description
Karfilzomib

Tender item

ID
ocds-pyfy63:2020-543335:obj:50
Classification
CPV / 33652000
Description
Blinatumomab

Tender item

ID
ocds-pyfy63:2020-543335:obj:51
Classification
CPV / 33652000
Description
Daratumumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:52
Classification
CPV / 33652000
Description
Temozolomidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:53
Classification
CPV / 33652000
Description
Temozolomidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:54
Classification
CPV / 33652000
Description
Abemacyklib

Tender item

ID
ocds-pyfy63:2020-543335:obj:55
Classification
CPV / 33652000
Description
Pegasparagasum

Tender item

ID
ocds-pyfy63:2020-543335:obj:56
Classification
CPV / 33652000
Description
Chlorambucilum

Tender item

ID
ocds-pyfy63:2020-543335:obj:57
Classification
CPV / 33652000
Description
Peginterferon alfa 2a

Tender item

ID
ocds-pyfy63:2020-543335:obj:58
Classification
CPV / 33652000
Description
Triflurydyna+ Typiracy

Tender item

ID
ocds-pyfy63:2020-543335:obj:59
Classification
CPV / 33652000
Description
Kladrybina

Tender item

ID
ocds-pyfy63:2020-543335:obj:60
Classification
CPV / 33652000
Description
Okrelizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:61
Classification
CPV / 33652000
Description
Natalizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:62
Classification
CPV / 33652000
Description
Natalizumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:63
Classification
CPV / 33652000
Description
Alemtuzumabum

Tender item

ID
ocds-pyfy63:2020-543335:obj:64
Classification
CPV / 33652000
Description
Interferon β- 1a

Tender item

ID
ocds-pyfy63:2020-543335:obj:65
Classification
CPV / 33652000
Description
Fumaran dimetylu

Tender item

ID
ocds-pyfy63:2020-543335:obj:66
Classification
CPV / 33652000
Description
Mmunoglobuliny

Tender item

ID
ocds-pyfy63:2020-543335:obj:67
Classification
CPV / 33652000
Description
Cetuximab

Tender item

ID
ocds-pyfy63:2020-543335:obj:68
Classification
CPV / 33652000
Description
Dexamethasoni phosphas

Tender item

ID
ocds-pyfy63:2020-543335:obj:69
Classification
CPV / 33652000
Description
Dexamethasoni phosphas

Tender item

ID
ocds-pyfy63:2020-543335:obj:70
Classification
CPV / 33652000
Description
Anagrelid

Tender item

ID
ocds-pyfy63:2020-543335:obj:71
Classification
CPV / 33652000
Description
Ponatynib

Tender item

ID
ocds-pyfy63:2020-543335:obj:72
Classification
CPV / 33652000
Description
Romiplostym

Tender item

ID
ocds-pyfy63:2020-543335:obj:73
Classification
CPV / 33652000
Description
Cladribinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:74
Classification
CPV / 33652000
Description
Cyclophosphamidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:75
Classification
CPV / 33652000
Description
Cyclophosphamidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:76
Classification
CPV / 33652000
Description
Fludarabina ORAL

Tender item

ID
ocds-pyfy63:2020-543335:obj:77
Classification
CPV / 33652000
Description
Hydroxycarbamidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:78
Classification
CPV / 33652000
Description
Idarubicin

Tender item

ID
ocds-pyfy63:2020-543335:obj:79
Classification
CPV / 33652000
Description
Ifosfamid

Tender item

ID
ocds-pyfy63:2020-543335:obj:80
Classification
CPV / 33652000
Description
Mercaptopurinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:81
Classification
CPV / 33652000
Description
Mesna

Tender item

ID
ocds-pyfy63:2020-543335:obj:82
Classification
CPV / 33652000
Description
Tioguanine

Tender item

ID
ocds-pyfy63:2020-543335:obj:83
Classification
CPV / 33652000
Description
Topotecan

Tender item

ID
ocds-pyfy63:2020-543335:obj:84
Classification
CPV / 33652000
Description
Carboplatin

Tender item

ID
ocds-pyfy63:2020-543335:obj:85
Classification
CPV / 33652000
Description
Cisplatinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:86
Classification
CPV / 33652000
Description
Cytarabina

Tender item

ID
ocds-pyfy63:2020-543335:obj:87
Classification
CPV / 33652000
Description
Docetaxel

Tender item

ID
ocds-pyfy63:2020-543335:obj:88
Classification
CPV / 33652000
Description
Doxorubicinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:89
Classification
CPV / 33652000
Description
Epirubicin

Tender item

ID
ocds-pyfy63:2020-543335:obj:90
Classification
CPV / 33652000
Description
Etoposidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:91
Classification
CPV / 33652000
Description
Fluorouracilum

Tender item

ID
ocds-pyfy63:2020-543335:obj:92
Classification
CPV / 33652000
Description
Gemcitabina

Tender item

ID
ocds-pyfy63:2020-543335:obj:93
Classification
CPV / 33652000
Description
Methotrexatum

Tender item

ID
ocds-pyfy63:2020-543335:obj:94
Classification
CPV / 33652000
Description
Methotrexatum

Tender item

ID
ocds-pyfy63:2020-543335:obj:95
Classification
CPV / 33652000
Description
Mitoxantron

Tender item

ID
ocds-pyfy63:2020-543335:obj:96
Classification
CPV / 33652000
Description
Paclitaxel

Tender item

ID
ocds-pyfy63:2020-543335:obj:97
Classification
CPV / 33652000
Description
Pemetrexed

Tender item

ID
ocds-pyfy63:2020-543335:obj:98
Classification
CPV / 33652000
Description
Vinorelbin

Tender item

ID
ocds-pyfy63:2020-543335:obj:99
Classification
CPV / 33652000
Description
Capecytabina

Tender item

ID
ocds-pyfy63:2020-543335:obj:100
Classification
CPV / 33652000
Description
Bleomycinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:101
Classification
CPV / 33652000
Description
Dacarbazinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:102
Classification
CPV / 33652000
Description
Topotecan

Tender item

ID
ocds-pyfy63:2020-543335:obj:103
Classification
CPV / 33652000
Description
Lipegfilgrastym

Tender item

ID
ocds-pyfy63:2020-543335:obj:104
Classification
CPV / 33652000
Description
Bicalutamid

Tender item

ID
ocds-pyfy63:2020-543335:obj:105
Classification
CPV / 33652000
Description
Doxorubicinum liposomanum nonpegylatum

Tender item

ID
ocds-pyfy63:2020-543335:obj:106
Classification
CPV / 33652000
Description
Vincristinum

Tender item

ID
ocds-pyfy63:2020-543335:obj:107
Classification
CPV / 33652000
Description
Denozumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:108
Classification
CPV / 33652000
Description
Panitumumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:109
Classification
CPV / 33652000
Description
Trastuzumab

Tender item

ID
ocds-pyfy63:2020-543335:obj:110
Classification
CPV / 33652000
Description
Bortezomib

Tender item

ID
ocds-pyfy63:2020-543335:obj:111
Classification
CPV / 33652000
Description
Lenalidomid

Tender item

ID
ocds-pyfy63:2020-543335:obj:112
Classification
CPV / 33652000
Description
Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą

Tender item

ID
ocds-pyfy63:2020-543335:obj:113
Classification
CPV / 33652000
Description
Palbocyklib

Tender item

ID
ocds-pyfy63:2020-543335:obj:114
Classification
CPV / 33652000
Description
Temozolomidum

Tender item

ID
ocds-pyfy63:2020-543335:obj:115
Classification
CPV / 33652000
Description
Melphalanum

Award

ID
ocds-pyfy63:2020-543335:award:0
Title
Leki przeciwnowotworowe
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:1
Title
Calcii folinas
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:2
Title
Filgasterim
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:3
Title
Irinotecan
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:4
Title
Bendamustine
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:5
Title
Capecytabina
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:6
Title
Gefitinibum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:7
Title
Oxaliplatin
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:8
Title
BCG Vaccinum
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:9
Title
Ac. levofolicum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:10
Title
Darbopoetyna alfa
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:11
Title
Bevacizumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:12
Title
Erlotinib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:13
Title
Rituximab
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:14
Title
Obinutuzumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:15
Title
Peruzumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:16
Title
Trastuzumab
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:17
Title
Olaparyb
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:18
Title
Doxorubicinum lizosomalna pegylatum
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:19
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:20
Title
Bortezomib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:21
Title
Anagrelid
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:22
Title
Lapatinib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:23
Title
Cytarabina liposomalna
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:24
Title
Azacytydyna
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:25
Title
Octan abirateronu
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:26
Title
Farmacol Logistyka Sp. z o.o. ul. Szopienicka 77, 40-431 Katowice
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:27
Title
Imatinib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:28
Title
Afatynib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:29
Title
Enzalutamid
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:30
Title
Ozymertynib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:31
Title
Ruksolitynib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:32
Title
Ibrutynib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:33
Title
Eltrombopag
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:34
Title
Piksantron dimaleas
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:35
Title
Dasatynib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:36
Title
Brentuksymab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:37
Title
Aflibercept
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:38
Title
Pomalidomid
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:39
Title
Nintedanib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:40
Title
Fluvestrant
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:41
Title
Atezolizumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:42
Title
Niwolumab
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:43
Title
Kryzotynib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:44
Title
Pembrolizumab
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:45
Title
Wenetoklaks
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:46
Title
Alektynib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:47
Title
Transtuzumab ematyzyna
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:48
Title
Karfilzomib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:49
Title
Blinatumomab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:50
Title
Daratumumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:51
Title
Temozolomidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:52
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:53
Title
Abemacyklib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:54
Title
Pegasparagasum
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:55
Title
Chlorambucilum
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:56
Title
Peginterferon alfa 2a
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:57
Title
Triflurydyna+ Typiracy
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:58
Title
Kladrybina
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:59
Title
Okrelizumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:60
Title
Natalizumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:61
Title
Fingolimod
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:62
Title
Alemtuzumabum
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:63
Title
Interferon β- 1a
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:64
Title
Fumaran dimetylu
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:65
Title
Immunoglobuliny
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:66
Title
Cetuximab
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:67
Title
Dexamethasoni phosphas
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:68
Title
Netupitantum + Palonosetroni hydrochloridum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:69
Title
Anagrelid
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:70
Title
Ponatynib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:71
Title
Romiplostym
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:72
Title
Cladribinum
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:73
Title
Cyclophosphamidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:74
Title
Cyclophosphamidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:75
Title
Fludarabina ORAL
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:76
Title
Hydroxycarbamidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:77
Title
Idarubicin
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:78
Title
Ifosfamid
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:79
Title
Mercaptopurinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:80
Title
Mesna
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:81
Title
Tioguanine
Status
unsuccessful

Award

ID
ocds-pyfy63:2020-543335:award:82
Title
Topotecan
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:83
Title
Carboplatin
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:84
Title
Cisplatinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:85
Title
Cytarabina
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:86
Title
Docetaxel
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:87
Title
Doxorubicinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:88
Title
Epirubicin
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:89
Title
Etoposidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:90
Title
Fluorouracilum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:91
Title
Gemcitabina
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:92
Title
Methotrexatum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:93
Title
Methotrexatum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:94
Title
Mitoxantron
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:95
Title
Paclitaxel
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:96
Title
Pemetrexed
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:97
Title
Vinorelbin
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:98
Title
Capecytabina
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:99
Title
Bleomycinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:100
Title
Dacarbazinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:101
Title
Topotecan
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:102
Title
Lipegfilgrastym
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:103
Title
Bicalutamid
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:104
Title
Doxorubicinum liposomanum nonpegylatum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:105
Title
Vincristinum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:106
Title
Denozumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:107
Title
Panitumumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:108
Title
Trastuzumab
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:109
Title
Bortezomib
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:110
Title
Lenalidomid
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:111
Title
Paklitaksel w postaci nanocząsteczkowego kompleksu z albuminą
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:112
Title
Palbocyklib
Date
2021-01-12
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:113
Title
Temozolomidum
Date
2021-01-26
Status
active

Award

ID
ocds-pyfy63:2020-543335:award:114
Title
Melphalanum
Status
unsuccessful

Parties

Roles
buyer
Organization name
Szpital Specjalistyczny im. Jędrzeja Śniadeckiego w Nowym Sączu
Street address
ul. Młyńska 10
Locality
Nowy Sącz
Postal code
33-300
Country
PL
Contact name
Ryszard Tobiasz
E-mail
zamowieniapubliczne@szpitalnowysacz.pl
Phone
+48 184436635
Fax
+48 184436635
Website
www.szpitalnowysacz.pl

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Asclepios SA. ul. Hubska 44 50-502
Locality
Wrocław
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Lek S.A. ul. Podlipie 16, 95-010
Locality
Stryków
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Neuca SA., ul. Forteczna 35-37, 87-100
Locality
Toruń
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Amgen Sp. z o.o. ul. Puławska 145 02-715
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Salus International Sp. z o. o. ul. Pułaskiego 9, 40-273
Locality
Katowice
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
6/Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
6/ Roche Polska Sp. z o.o. ul. Domaniewska 39B 02-672
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
Locality
Wrocław
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
PGF SA. ul. Zbąszyńska 3, 91-342
Locality
Łódź
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Astra Zeneca AB 151 85 SŐDERTӒLIE SWEDEN
Locality
SŐDERTӒLIE
Country
SE

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Janssen-Cilag Polska Sp. z o.o ul. Iłżecka 24, 02-135
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
/Bialmed Sp. z o.o. ul. Kazimierzowska 46/48/35, 02-546
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Farmacol Logistyka Sp. z o.o. ul. Szopienicka 77, 40-431
Locality
Katowice
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Astellas Pharma Sp. z o.o. ul. Osmańska 14 02-823
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Astra Zeneca AB 151 85 SWEDEN
Locality
SŐDERTӒLIE
Country
SE

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Servier Polska Services Sp. z o.o. ul. Jana Kazimierza 10, 01-248
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Takeda Pharma Sp. z o.o. ul. Prosta 68, 00-838
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Sanofi-Aventis Sp. z o.o., 00-203 ul. Bonifraterska 17
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Komtur Polska Sp. z o.o. ul. Plac Farmacji 1, 02-699
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Pfizer Trading Polska Sp. z o.o. ul. Żwirki i Wigury 16B 02-092
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Abbvie Sp. z o.o. ul. Postępu 21B, 02-676
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Centrala Farmaceutyczna CEFARM SA 01-494 ul. Jana Kazimierza 16
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
9/Servier Polska Services Sp. z o.o. ul. Jana Kazimierza 10, 01-248
Locality
Warszawa
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Konsorcjum: Urtica Sp. z o.o. ul Krzemieniecka 120, 54-613
Locality
Wrocław
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
11/Farmacol Logistyka Sp. z o.o. ul. Szopienicka 77, 40-431
Locality
Katowice
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Urtica Sp. z o.o. ul Krzemieniecka 12054-613
Locality
Wrocław
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Asclepios SA. ul. Hubska 44 50-502 Wrocław
Locality
Wrocław
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Genesis Pharm Sp. z o.o. Sp. k. ul. Obywatelska 128, 94-104
Locality
Łódź
Country
PL

Organization data Organization in JSON

Roles
supplier
tenderer
Organization name
Fresenius Kabi Polska Sp. z o.o. Al. Jerozolimskie 114 02-305
Locality
Warszawa
Country
PL

Organization data Organization in JSON